Corsair Pharma
Corsair Pharma is a biopharmaceutical company focused on developing innovative prodrugs of treprostinil for the treatment of pulmonary arterial hypertension (PAH) using a once-daily transdermal patch. The company's mission is to improve the therapeutic profile of medications and provide superior treatment options for patients, aiming to offer safer, more effective, and more convenient therapies.
Industries
Nr. of Employees
small (1-50)
Corsair Pharma
5600 Mowry School Road, Suite 330, Newark, CA 94560
Patents
Products
Once-daily transdermal prodrug patch for treprostinil
A once-daily transdermal patch that delivers an inactive prodrug across the skin; the prodrug is intended to enter systemic circulation and rapidly convert to the active prostacyclin drug in the liver to provide steady blood levels.
Once-daily transdermal prodrug patch for treprostinil
A once-daily transdermal patch that delivers an inactive prodrug across the skin; the prodrug is intended to enter systemic circulation and rapidly convert to the active prostacyclin drug in the liver to provide steady blood levels.
Services
Conduct of preclinical formulation optimization, animal pharmacokinetic studies and GLP toxicology studies to generate regulatory‑enabling safety and PK data.
Preparation and sponsorship of Phase 1 human studies focused on PK and safety/tolerability to support first-in-human evaluation.
Negotiation and management of strategic collaborations, exclusive licensing arrangements, and investor relations to advance development and potential commercialization.
Conduct of preclinical formulation optimization, animal pharmacokinetic studies and GLP toxicology studies to generate regulatory‑enabling safety and PK data.
Preparation and sponsorship of Phase 1 human studies focused on PK and safety/tolerability to support first-in-human evaluation.
Negotiation and management of strategic collaborations, exclusive licensing arrangements, and investor relations to advance development and potential commercialization.
Expertise Areas
- Transdermal drug delivery
- Prodrug chemistry and design
- Preclinical development and GLP toxicology
- Pharmacokinetics and PK optimization
Key Technologies
- Transdermal delivery systems
- Prodrug chemistry
- Pharmacokinetic (PK) analysis
- GLP toxicology studies